Sinopharm (company) explained

39.9747°N 116.3401°W

China National Pharmaceutical Group Corporation
Trade Name:Sinopharm
Type:State-owned enterprise
Hq Location:20 Zhichun Road, Haidian District
Hq Location City:Beijing
Hq Location Country:China
Area Served:China, exported worldwide
Key People:Liu Jingzhen (chairman & Chinese Communist Party Committee Secretary)[1] [2]
Revenue Year:2014
Income Year:2014
Net Income Year:2014
Assets Year:2014
Equity Year:2014
Owner:Chinese central government (100%)
Parent:SASAC of the State Council
Footnotes:in a consolidated basis; equity and profit excluded minority interests; in Chinese Accounting Standards[3]

China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group (via a 51–49 joint venture, Sinopharm Industrial Investment, with Fosun Pharmaceutical), (mostly via Sinopharm Group Hongkong Co., Ltd.),[4] Shanghai Shyndec Pharmaceutical (via a wholly owned research institute based in Shanghai), and Beijing Tiantan Biological Products (via China National Biotec Group).

China National Pharmaceutical Group was supervised by the State-owned Assets Supervision and Administration Commission of the State Council.[5]

Sinopharm was ranked 109th in the 2021 Fortune Global 500 list.[6]

History

Sinopharm was founded as China National Pharmaceutical Group Corporation on November 26, 1998, as a holding company for China National Pharmaceutical Corporation, China National Pharmaceutical Industry Corporation, China National Pharmaceutical Foreign Trade Corp. and China National Medical Device . In 2009 it was merged with China National Biotec Group .

Its subsidiary Wuhan Institute of Biological Products was fined for selling 400,520 ineffective DPT vaccines in November 2017.[7]

Pfizer announced the signing of a cooperation pact with Sinopharm Group in April 2023, with plans to seep approval for 12 drugs in China through 2025.[8]

COVID-19 vaccines

See main article: Sinopharm BIBP COVID-19 vaccine, Sinopharm WIBP COVID-19 vaccine and Sinopharm CNBG COVID-19 vaccine.

The Sinopharm BIBP COVID-19 vaccine, also known as BBIBP-CorV,[9] the Sinopharm COVID-19 vaccine,[10] or BIBP vaccine,[10] [11] [12] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. It completed Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants.[13] BBIBP-CorV shares similar technology with CoronaVac and BBV152, other inactivated virus vaccines for COVID-19.[14]

Peer-reviewed results published in JAMA of Phase III trials in United Arab Emirates and Bahrain showed BBIBP-CorV 78.1% effective against symptomatic cases and 100% against severe cases (21 cases in vaccinated group vs. 95 cases in placebo group).[15] In December 2020, the UAE previously announced interim results showing 86% efficacy.[16] While mRNA vaccines like the Pfizer–BioNTech COVID-19 vaccine and mRNA-1273 showed higher efficacy of over 90%, those present distribution challenges for some nations as they require deep-freeze facilities and trucks. BIBP-CorV could be transported and stored at normal refrigerated temperatures.[17]

BBIBP-CorV is being used in vaccination campaigns by certain countries in Asia,[18] [19] [20] Africa,[21] [22] [23] South America,[24] [25] [26] and Europe.[27] [28] [29] Sinopharm expects to produce one billion doses of BBIBP-CorV in 2021.[30] On 7 May 2021, the World Health Organization approved the vaccine for emergency use[31] and Sinopharm later signed purchase agreements for 170 million doses from COVAX.[32]

The similarly named Sinopharm WIBP COVID-19 vaccine is also an inactivated virus vaccine.

See also

Notes and References

  1. Web site: 中国医药集团有限公司主要领导调整. Sinopharm. zh. 2021-08-24. 2022-09-08. https://web.archive.org/web/20220908065805/http://www.sinopharm.com/s/1223-3764-36260.html. dead.
  2. Web site: Liu Jingzhen. Bloomberg. en.
  3. Web site: 中国医药集团总公司2016年度第一期超短期融资券发行披露材料. Pospectus of 2016 (batch 1) Ultra-short-term financing of Sinopharm. 19 January 2016. 22 November 2016. Sinopharm. Shanghai Clearing House. zh.
  4. Web site: 2015 Annual Report. 28 April 2016. 22 November 2016. China Traditional Chinese Medicine. Hong Kong Stock Exchange.
  5. Web site: 央企名录 (List of Central SOEs) . Official website of SASAC . 3 March 2016 . zh.
  6. Web site: Global 500.
  7. News: 23 July 2018. Chinese President Xi Jinping orders crackdown over 'appalling' vaccine scandal. South China Morning Post. 29 November 2018.
  8. News: 2023-04-13 . Pfizer signs strategic cooperation pact with China's Sinopharm . en . Reuters . 2023-11-08.
  9. Xia S, Zhang Y, Wang Y, Wang H, Yang Y, Gao GF, Tan W, Wu G, Xu M, Lou Z, Huang W, Xu W, Huang B, Wang H, Wang W, Zhang W, Li N, Xie Z, Ding L, You W, Zhao Y, Yang X, Liu Y, Wang Q, Huang L, Yang Y, Xu G, Luo B, Wang W, Liu P, Guo W, Yang X . 6 . Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial . The Lancet. Infectious Diseases . 21 . 1 . 39–51 . January 2021 . 33069281 . 7561304 . 10.1016/s1473-3099(20)30831-8 .
  10. News: The Sinopharm COVID-19 vaccine: What you need to know . 5 July 2021 . World Health Organization . 10 May 2021.
  11. News: Nguyen S . Coronavirus: Vietnam approves Sinopharm's vaccine, but will people take it? . 5 July 2021 . South China Morning Post . 5 June 2021.
  12. News: Lahiri T, Li J . What we now know about the efficacy of China's Covid-19 vaccines . 5 July 2021 . Quartz . 16 June 2021.
  13. News: Liu. Roxanne. Munroe. Tony. Sarkar. Himani. 2020-11-19. China Sinopharm's coronavirus vaccine taken by about a million people in emergency use. Reuters. Beijing. 2023-01-19.
  14. News: Corum. Jonathan. Zimmer. Carl. 2021-04-26. How the Sinopharm Vaccine Works. The New York Times. 2021-04-29. 0362-4331.
  15. Kaabi. Nawal Al. Zhang. Yuntao. Xia. Shengli. Yang. Yunkai. Qahtani. Manaf M. Al. Abdulrazzaq. Najiba. Nusair. Majed Al. Hassany. Mohamed. Jawad. Jaleela S.. Abdalla. Jehad. Hussein. Salah Eldin. 3. May 26, 2021. Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial. JAMA. en. 10.1001/jama.2021.8565. Yuxiu. Yang. Wei. Lai. Bonan. Chen. Wei. Huang. Shihe. Wang. Qian. Yang. Tian. Liu. Ma. Zhao. Jiang. Xinguo. Hussain. Zaidoon M.. Khan. Tehmina. Fasihuddin. Mohammed Saifuddin. You. Wangyang. Xie. Zhiqiang. Wang. Zhao. Xuqin. Zaher. Yang. Walid Abbas. Zhang. Yanbo. Mahmoud. Sally. ElTantawy. Islam. Xiao. Peng. Koshy. Ashish. Hui. Zhiwei. Wang. Duan. Kai. Pan. An. Yang. Xiaoming. Li. Maysoon Al. Karam. Shamma K. Al. Mazrouei. Guoqing. Rui. 326. 1. 35–45. 34037666. 8156175. free.
  16. Web site: UAE: Ministry of Health announces 86 per cent vaccine efficacy. 2020-12-13. gulfnews.com. 9 December 2020 . en.
  17. News: 2020-12-09. China State-Backed Covid Vaccine Has 86% Efficacy, UAE Says. en. Bloomberg.com. 2020-12-09.
  18. News: 2020-12-31. China gives its first COVID-19 vaccine approval to Sinopharm. Reuters. 2020-12-31. Liu R.
  19. Web site: Turak. Natasha. 2021-01-18. The UAE is on track to have half its population vaccinated by the end of March. 2021-01-21. CNBC.
  20. Web site: Dawn.com. 2021-02-02. PM Imran kicks off Pakistan's Covid-19 vaccination drive. 2021-02-03. DAWN.COM. en.
  21. News: Waly. Mohamed. Eltahir. Nafisa. Richardson. Alex. 2021-01-24. Sisi says Egypt to begin COVID-19 vaccinations on Sunday. Reuters. Cairo. 2023-01-19.
  22. Web site: Dumpis. Toms. 2021-01-27. Morocco Receives Half a Million Doses of Chinese Sinopharm Vaccine. 2021-01-28. Morocco World News.
  23. Web site: 2021-02-18. Zimbabwe starts administering China's Sinopharm vaccines. 2021-02-20. thestar.com. en.
  24. Web site: Argentina autoriza la vacuna china Sinopharm para mayores de 60 años. 2021-03-26. El Comercio.
  25. News: Aquino. Marco. 2021-02-10. 'The best shield': Peru launches inoculation drive with Sinopharm vaccine. en. Reuters. 2021-02-10.
  26. Web site: Bolivia begins inoculation with Sinopharm jabs The Star. 2021-02-28. www.thestar.com.my.
  27. News: Serbia Becomes First European Nation To Use China's Sinopharm Vaccine. 2021-01-21. Radio Free Europe/Radio Liberty. 20 January 2021 .
  28. Web site: 2021-02-24. Hungary first EU nation to use China's Sinopharm vaccine against COVID. 2021-02-26. euronews. en.
  29. Web site: 2021-03-15. Belarus begins COVID-19 vaccinations with Chinese shots. 2021-03-16. eng.belta.by. en-EN.
  30. Web site: 2021-02-05. Which companies will likely produce the most COVID-19 vaccine in 2021?. 2021-02-28. Pharmaceutical Processing World. en-US.
  31. News: Taylor. Adam. 7 May 2021. WHO grants emergency use authorization for Chinese-made Sinopharm coronavirus vaccine. The Washington Post. 7 May 2021.
  32. Web site: 2021-07-12. Chinese drugmakers agree to supply more than half a billion vaccines to COVAX. 2021-07-13. Reuters.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Sinopharm (company)".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.